Fact CheckerSign in

NCT07686562Completed

Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest Radiography

Evaluating the Real-World Performance of Artificial Intelligence (AI)-Based Detection for Interstitial Lung Disease in Chest X-Ray Images

Source: ClinicalTrials.gov · Last updated 7 Jul 2026

Brief summary (registry, in English)

The goal of this observational study is to learn how well an artificial intelligence (AI)-based chest X-ray analysis software can incidentally detect interstitial lung disease (ILD), which appears as interstitial opacity, on chest X-rays taken for other reasons, and whether these AI-flagged findings represent true interstitial opacity. The main question it aims to answer is: How often does an AI-flagged interstitial opacity correspond to true ILD? This retrospective study uses existing records: researchers review each participant's follow-up computed tomography(CT), CT report, and final diagnosis to confirm true ILD and reticular opacity.

Status (registry)
Completed
Study type
Observational
Enrollment
1293 (actual)
First submitted
25 Jun 2026
Start date
1 Feb 2022
Primary completion date
31 Dec 2024
Lead sponsor
Chung-Ang University Hospital
NCT number
NCT07686562

What you commit to

  • Study type: Observational
  • Participants enrolled: 1293
  • From 1 Feb 2022 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior history of ILD or ILD-related disease before the index chest radiograph, or a CT report containing terms related to interstitial opacity

Other

  • Non-frontal (non-posteroanterior/anteroposterior \[PA/AP\]) chest radiograph view position
  • Missing CT report or final clinical diagnosis

Who the study is looking for

  • Adults aged 19 years or older
  • Visited the pulmonology and allergy clinic (outpatient or inpatient) at Chung-Ang University Hospital (Seoul or Gwangmyeong) and underwent chest radiography from January 2022 to December 2024
  • A follow-up CT performed after the index chest radiograph
  • Reticular/interstitial opacity detected on the index radiograph by VUNO Med®-Chest X-ray™

Age in the registry: 19 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chung ang University Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.